A Phase 3, Long-Term, Open-Label Safety Study of Self-Administered Galcanezumab Injections in Patients with Migraine

被引：0
|
作者：
Stauffer, Virginia L. [1 ]
Sides, Ryan [1 ]
Camporeale, Angelo [1 ]
Skljarevski, Vladimir [1 ]
Ahl, Jonna [1 ]
Aurora, Sheena K. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
CEPHALALGIA | 2017年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PO-01-184
引用
收藏
页码：330 / 331
页数：2
相关论文
共 50 条
  • [41] Shift from chronic migraine to episodic migraine status in a long-term phase 3 study of galcanezumab
    Detke, H.
    Day, K.
    Lipsius, S.
    Aurora, S. K.
    Hindiyeh, N.
    Diener, H-C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 425 - 425
  • [42] Long-term treatment with lasmiditan in patients with migraine: Results from the open-label extension of the CENTURION study
    Ashina, M.
    Roos, C.
    Ayer, D. W.
    Ruff, D.
    Krege, J. H.
    Li, L. Q.
    Komori, M.
    HEADACHE, 2022, 62 : 113 - 114
  • [43] Long-Term Treatment With Lasmiditan in Patients With Migraine: Results From the Open-Label Extension of the CENTURION Study
    Ashina, M.
    Roos, C.
    Ayer, D.
    Ruff, D.
    Krege, J.
    Li, L. Q.
    Komori, M.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [44] Long-term safety of brodalumab in Japanese patients with plaque psoriasis: An open-label extension study
    Yamaguchi, Yukie
    Takatsu, Nobumichi
    Ootaki, Kenji
    Nakagawa, Hidemi
    JOURNAL OF DERMATOLOGY, 2020, 47 (06): : 569 - 577
  • [45] Tolerability and safety of topiramate in chinese patients with epilepsy - An open-label, long-term, prospective study
    Lu, Yang
    Wang, Xuefeng
    Li, Qihua
    Li, Jingmei
    Yan, Yong
    CLINICAL DRUG INVESTIGATION, 2007, 27 (10) : 683 - 690
  • [46] Tolerability and Safety of Topiramate in Chinese Patients with EpilepsyAn Open-Label, Long-Term, Prospective Study
    Yang Lu
    Xuefeng Wang
    Qihua Li
    Jingmei Li
    Yong Yan
    Clinical Drug Investigation, 2007, 27 : 683 - 690
  • [47] An Open-Label Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (RECAP)
    Costabel, Ulrich
    Albera, Carlo
    Lancaster, Lisa H.
    Lin, Chin-Yu
    Hormel, Philip
    Hulter, Henry N.
    Noble, Paul W.
    RESPIRATION, 2017, 94 (05) : 408 - 415
  • [48] Rimegepant is Safe and Tolerable for the Acute Treatment of Migraine in Patients Using Preventive Migraine Medications: Results from a Long-Term Open-Label Safety Study
    Schim, Jack
    Hutchinson, Susan
    Lipton, Richard
    Croop, Robert
    Stock, Elyse
    Thiry, Alexandra
    Conway, Charles
    Lovegren, Meghan
    Coric, Vlad
    Jensen, Christopher
    NEUROLOGY, 2021, 96 (15)
  • [49] Safety of Evobrutinib in Patients With Relapsing Multiple Sclerosis is Maintained in a Long-term Open-label Extension of a Phase II Study
    Montalban, Xavier
    Arnold, Douglas L.
    Weber, Martin S.
    Staikov, Ivan
    Piasecka-Stryczynska, Karolina
    Martin, Emily C.
    Mandel, Matthew
    Zima, Yulia
    Shaw, Jamie
    Dangond, Fernando
    Grenningloh, Roland
    Li, Ying
    Tomic, Davorka
    Wolinsky, Jerry S.
    NEUROLOGY, 2021, 96 (15)
  • [50] Long-term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open-label extension study
    Reshef, Avner
    Hsu, Connie
    Katelaris, Constance H.
    Li, Philip H.
    Magerl, Markus
    Yamagami, Keiko
    Guilarte, Mar
    Keith, Paul K.
    Bernstein, Jonathan A.
    Lawo, John-Philip
    Shetty, Harsha
    Pollen, Maressa
    Wieman, Lolis
    Craig, Tim J.
    ALLERGY, 2025, 80 (02) : 545 - 556
12345